USD 13.84
| ticker | 1 day return % | 1 week return % | 1 month return % | 3 months return % | 6 months return % | 1 year return % | 3 years return % | 5 years return % | 10 years return % | maximum return % |
|---|---|---|---|---|---|---|---|---|---|---|
| MD | 0.5 | 10.7 | -2.7 | 9.2 | 77.4 | 48.5 | -46.6 | -50.0 | -78.7 | 159.0 |
| S&P 500 | 1.0 | 1.8 | -0.9 | 2.7 | 7.3 | 26.5 | 31.0 | 80.1 | 196.5 | 33856.2 |
Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline
Feel free to experiment with these tools to enhance your technical analysis. Remember, any drawings you make are temporary and will be lost upon refreshing the page unless saved as an image using the 'Camera' icon.
Get instant AI-powered professional insights on prices:
💡Generate AI Technical Analysis ReportA Multi-Interval Candlestick Chart displays the price movements of an asset over different time intervals. Each candlestick represents the open, high, low, and close prices for a specific interval. The chart can be used to identify trends and patterns in price movements.
| Attribute | Value |
|---|---|
| symbol | MD |
| name | Pediatrix Medical Group, Inc. |
| price | 13.84 |
| changes percentage | 0.5084 |
| change | 0.07 |
| day low | 13.685 |
| day high | 13.94 |
| year high | 16.41 |
| year low | 6.62 |
| market cap | 1188586120 |
| price avg 50 | 14.3058 |
| price avg 200 | 10.6493 |
| exchange | NYSE |
| volume | 349869 |
| avg volume | 724449 |
| open | 13.83 |
| previous close | 13.77 |
| eps | -2.34 |
| pe | -5.91 |
| earnings announcement | 2025-02-20T13:30:00.000+0000 |
| shares outstanding | 85880500 |
| timestamp | 2025-01-17 21:00:02 |
We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0000893949 | |||
| revenue | 1994640000 | 1972021000 | 1.15 |
| gross profit | 421565000 | 467033000 | -9.74 |
| gross profit ratio | 0.21 | 0.24 | -10.76 |
| research and development expenses | 0 | 0 | NaN |
| operating expenses | 414244000 | 267033000 | 55.13 |
| interest income | 0 | 3671000 | -100.00 |
| interest expense | 42075000 | 39695000 | 6.00 |
| ebitda | 29887000 | 235636000 | -87.32 |
| ebitdaratio | 0.01 | 0.12 | -87.55 |
| operating income | 7321000 | 172688000 | -95.76 |
| operating income ratio | 0.0 | 0.09 | -95.81 |
| net income | -60408000 | 66335000 | -191.07 |
| net income ratio | -0.03 | 0.03 | -190.03 |
| eps | -0.72 | 0.79 | -191.14 |
Revenue Growth: revenue increased to 1,995 million in 2023 from 1,972 million in 2022 representing a change of 1.15%. This indicates a sales growth, which is a positive sign for the company.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 30 million in 2023 from 236 million in 2022 representing a change of -87.32%. The increase in EBITDA indicates improved operational efficiency and profitability.
Operating Income: Operating income increased to 7 million in 2023 from 173 million in 2022 representing a change of -95.76%. The increase in operating income indicates better operational performance and increased profitability.
Gross Profit: Gross Profit decreased to 422 million in 2023 from 467 million in 2022 representing a change of -9.74%. This indicates a sales profitability decline, which is a negative sign for the company.
Operating Expenses: Operating Expenses increased to 414 million in 2023 from 267 million in 2022 representing a change of 55.13%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
Net Income: Net income decreased to -60 million in 2023 from 66 million in 2022 representing a change of -191.07%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to -0.72 in 2023 from -0.72 in 2022 representing a change of -191.14%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0000893949 | |||
| revenue | 511158000 | 504296000 | 1.36 |
| gross profit | 116821000 | 105328000 | 10.91 |
| gross profit ratio | 0.23 | 0.21 | 9.42 |
| research and development expenses | 0 | 0 | NaN |
| operating expenses | 82994000 | 56565000 | 46.72 |
| interest income | 0 | 0 | NaN |
| interest expense | 10126000 | 10308000 | -1.77 |
| ebitda | 41615000 | -148629000 | 128.00 |
| ebitdaratio | 0.08 | 0.11 | -28.66 |
| operating income | 33827000 | 48763000 | -30.63 |
| operating income ratio | 0.07 | 0.1 | -31.56 |
| net income | 19441000 | -153025000 | 112.70 |
| net income ratio | 0.04 | -0.3 | 112.53 |
| eps | 0.23 | -1.84 | 112.50 |
Revenue Growth: revenue increased to 511 million in 2024Q3 from 504 million in 2024Q2 representing a change of 1.36%. This indicates a sales growth, which is a positive sign for the company.
Gross Profit: Gross Profit increased to 117 million in 2024Q3 from 105 million in 2024Q2 representing a change of 10.91%. This indicates a sales profitability growth, which is a positive sign for the company.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 42 million in 2024Q3 from -149 million in 2024Q2 representing a change of 128.0%. The increase in EBITDA indicates improved operational efficiency and profitability.
Net Income: Net income increased to 19 million in 2024Q3 from -153 million in 2024Q2 representing a change of 112.7%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to 0.23 in 2024Q3 from 0.23 in 2024Q2 representing a change of 112.5%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.
Operating Expenses: Operating Expenses increased to 83 million in 2024Q3 from 57 million in 2024Q2 representing a change of 46.72%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
Operating Income: Operating income decreased to 34 million in 2024Q3 from 49 million in 2024Q2 representing a change of -30.63%. The decrease in operating income indicates worse operational performance and decreased profitability.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0000893949 | |||
| total assets | 2219810000 | 2347887000 | -5.45 |
| total liabilities | 1370749000 | 1456255000 | -5.87 |
| total equity | 849061000 | 891632000 | -4.77 |
| cash and cash equivalents | 73258000 | 9824000 | 645.70 |
| short term investments | 104485000 | 93239000 | 12.06 |
| long term investments | 0 | 93239000 | -100.00 |
| total current assets | 483454000 | 334750000 | 44.42 |
| total non current assets | 1736356000 | 2013137000 | -13.75 |
| total current liabilities | 388946000 | 374225000 | 3.93 |
| total non current liabilities | 981803000 | 1082030000 | -9.26 |
| common stock | 840000 | 829000 | 1.33 |
| retained earnings | -149471000 | -89063000 | -67.83 |
| total debt | 701648000 | 753568000 | -6.89 |
Total Assets: Total Assets decreased to 2,220 million in 2023 from 2,348 million in 2022 representing a change of -5.45%. Suggesting a decrease in asset holdings.
Total Equity: Total Equity decreased to 849 million in 2023 from 892 million in 2022 representing a change of -4.77%. This indicates a decrease in shareholders' equity.
Total Current Liabilities: Total Current Liabilities increased to 389 million in 2023 from 374 million in 2022 representing a change of 3.93%. This indicates a higher short-term debt burden.
Retained Earnings: Retained Earnings decreased to -149 million in 2023 from -89 million in 2022 representing a change of -67.83%. This indicates an accumulated losses.
Total Liabilities: Total Liabilities decreased to 1,371 million in 2023 from 1,456 million in 2022 representing a change of -5.87%. This indicates a decrease in overall liabilities.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 73 million in 2023 from 10 million in 2022 representing a change of 645.7%. This indicates an increase in available liquid assets.
Short Term Investments: Short Term Investments increased to 104 million in 2023 from 93 million in 2022 representing a change of 12.06%. This indicates an increase in short-term investment holdings.
Total Current Assets: Total Current Assets increased to 483 million in 2023 from 335 million in 2022 representing a change of 44.42%. This indicates a better liquidity position.
Common Stock: Common Stock increased to 1 in 2023 from 1 in 2022 representing a change of 1.33%. This indicates an increase in ownership interest.
Total Debt: Total Debt decreased to 702 million in 2023 from 754 million in 2022 representing a change of -6.89%. This indicates a reduction in overall debt burden.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0000893949 | |||
| total assets | 2076873000 | 1995351000 | 4.09 |
| total liabilities | 1344381000 | 1288890000 | 4.31 |
| total equity | 732492000 | 706461000 | 3.68 |
| cash and cash equivalents | 103831000 | 19402000 | 435.16 |
| short term investments | 116621000 | 113795000 | 2.48 |
| long term investments | 0 | 29400000 | -100.00 |
| total current assets | 528215000 | 429212000 | 23.07 |
| total non current assets | 1548658000 | 1566139000 | -1.12 |
| total current liabilities | 373080000 | 310156000 | 20.29 |
| total non current liabilities | 971301000 | 978734000 | -0.76 |
| common stock | 859000 | 858000 | 0.12 |
| retained earnings | -279020000 | -298461000 | 6.51 |
| total debt | 683653000 | 698310000 | -2.10 |
Total Assets: Total Assets increased to 2,077 million in 2024Q3 from 1,995 million in 2024Q2 representing a change of 4.09%. Suggesting a growth in asset holdings.
Total Equity: Total Equity increased to 732 million in 2024Q3 from 706 million in 2024Q2 representing a change of 3.68%. This indicates an increase in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 104 million in 2024Q3 from 19 million in 2024Q2 representing a change of 435.16%. This indicates an increase in available liquid assets.
Short Term Investments: Short Term Investments increased to 117 million in 2024Q3 from 114 million in 2024Q2 representing a change of 2.48%. This indicates an increase in short-term investment holdings.
Total Current Assets: Total Current Assets increased to 528 million in 2024Q3 from 429 million in 2024Q2 representing a change of 23.07%. This indicates a better liquidity position.
Common Stock: Common Stock increased to 1 in 2024Q3 from 1 in 2024Q2 representing a change of 0.12%. This indicates an increase in ownership interest.
Retained Earnings: Retained Earnings increased to -279 million in 2024Q3 from -298 million in 2024Q2 representing a change of 6.51%. This indicates an accumulated profits.
Total Debt: Total Debt decreased to 684 million in 2024Q3 from 698 million in 2024Q2 representing a change of -2.1%. This indicates a reduction in overall debt burden.
Total Liabilities: Total Liabilities increased to 1,344 million in 2024Q3 from 1,289 million in 2024Q2 representing a change of 4.31%. This indicates an increase in overall liabilities.
Total Current Liabilities: Total Current Liabilities increased to 373 million in 2024Q3 from 310 million in 2024Q2 representing a change of 20.29%. This indicates a higher short-term debt burden.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0000893949 | |||
| net change in cash | 63434000 | -377567000 | 116.80 |
| operating cash flow | 137325000 | 166941000 | -17.74 |
| free cash flow | 103997000 | 137233000 | -24.22 |
| capital expenditure | -33328000 | -29708000 | -12.19 |
| depreciation and amortization | 36171000 | 35636000 | 1.50 |
| deferred income tax | 3239000 | -22771000 | 114.22 |
| stock based compensation | 12323000 | 16127000 | -23.59 |
| accounts payables | 0 | 420000 | -100.00 |
| inventory | 0 | 0 | NaN |
| acquisitions net | -6667000 | -28167000 | 76.33 |
| investments in property plant and equipment | -33328000 | -29708000 | -12.19 |
| net cash used for investing activites | -48176000 | -56954000 | 15.41 |
| debt repayment | -19118000 | -405171000 | 95.28 |
| common stock issued | 4912000 | 5396000 | -8.97 |
| common stock repurchased | -919000 | -88511000 | 98.96 |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | -25715000 | -487554000 | 94.73 |
| cash at end of period | 73258000 | 9824000 | 645.70 |
| accounts receivables | 26276000 | -5543000 | 574.04 |
| cash at beginning of period | 9824000 | 387391000 | -97.46 |
Net Change in Cash: Net Change in Cash increased to 63 million in 2023 from -378 million in 2022 representing a change of 116.8%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Capital Expenditure: Capital Expenditure decreased to -33 million in 2023 from -30 million in 2022 representing a change of -12.19%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.
Stock-Based Compensation: Stock-Based Compensation decreased to 12 million in 2023 from 16 million in 2022 representing a change of -23.59%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.
Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2023 from 0 million in 2022 representing a change of -100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.
Operating Cash Flow: Operating Cash Flow decreased to 137 million in 2023 from 167 million in 2022 representing a change of -17.74%. This indicates that the company generated less cash from its core business operations.
Free Cash Flow: Free Cash Flow decreased to 104 million in 2023 from 137 million in 2022 representing a change of -24.22%. This indicates a decrease in cash generated after accounting for capital expenditures.
Deferred Income Tax: Deferred Income Tax increased to 3 million in 2023 from -23 million in 2022 representing a change of 114.22%. This indicates that the company's tax liability for future periods has increased.
Accounts Receivables: Accounts Receivables increased to 26 in 2023 from -6 million in 2022 representing a change of 574.04%. This suggests that the company is less capable of collecting payments from its customers.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0000893949 | |||
| operating cash flow | 100720000 | 106951000 | -5.83 |
| free cash flow | 94430000 | 99989000 | -5.56 |
| capital expenditure | -6290000 | -6962000 | 9.65 |
| depreciation and amortization | 6957000 | 8791000 | -20.86 |
| deferred income tax | 9148000 | -25714000 | 135.58 |
| stock based compensation | 4110000 | 1952000 | 110.55 |
| accounts receivables | 1569000 | 9002000 | -82.57 |
| accounts payables | 48763000 | 58546000 | -16.71 |
| inventory | 0 | 0 | NaN |
| acquisitions net | 0 | 0 | NaN |
| investments in property plant and equipment | -6290000 | -6962000 | 9.65 |
| net cash used for investing activites | -4338000 | -12892000 | 66.35 |
| debt repayment | -3779000 | -83826000 | 95.49 |
| common stock issued | 897000 | 1149000 | -21.93 |
| common stock repurchased | -162000 | -11000 | -1372.73 |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | -3071000 | -82655000 | 96.28 |
| net change in cash | 84429000 | 11404000 | 640.35 |
| cash at end of period | 103831000 | 19402000 | 435.16 |
| cash at beginning of period | 19402000 | 7998000 | 142.59 |
Net Change in Cash: Net Change in Cash increased to 84 million in 2024Q3 from 11 million in 2024Q2 representing a change of 640.35%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Accounts Payables: The absolute value of Accounts Payables decreased to 49 million in 2024Q3 from 59 million in 2024Q2 representing a change of -16.71%. This indicates that the company has reduced its outstanding obligations to its suppliers.
Accounts Receivables: Accounts Receivables decreased to 2 million in 2024Q3 from 9 million in 2024Q2 representing a change of -82.57%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.
Operating Cash Flow: Operating Cash Flow decreased to 101 million in 2024Q3 from 107 million in 2024Q2 representing a change of -5.83%. This indicates that the company generated less cash from its core business operations.
Free Cash Flow: Free Cash Flow decreased to 94 million in 2024Q3 from 100 million in 2024Q2 representing a change of -5.56%. This indicates a decrease in cash generated after accounting for capital expenditures.
Capital Expenditure: Capital Expenditure increased to -6 million in 2024Q3 from -7 million in 2024Q2 representing a change of 9.65%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.
Deferred Income Tax: Deferred Income Tax increased to 9 million in 2024Q3 from -26 million in 2024Q2 representing a change of 135.58%. This indicates that the company's tax liability for future periods has increased.
Stock-Based Compensation: Stock-Based Compensation increased to 4 million in 2024Q3 from 2 million in 2024Q2 representing a change of 110.55%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.
We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.
Note: The years mentioned below are fiscal years in accounting.
Q3 2024 Earnings call transcript
EPS represents the portion of a company's profit allocated to each outstanding share of common stock. A higher EPS is generally favorable, indicating stronger profitability on a per-share basis.
Positive EPS: A positive EPS signifies that a company is profitable, it is generally viewed positively, supporting stock value and investor confidence.
Negative EPS: Indicates that a company is operating at a loss, which could lead to negative sentiment, potential stock depreciation, and concerns about the company's financial health.
The Next Earning Date represents when the company plans to release its next set of financial results.
An upward trend in EPS suggests consistent growth in earnings, often leading to increased investor confidence. A downward trend may indicate a decline in earnings, potentially decreasing investor confidence and stock value. Fluctuating EPS suggests unpredictable financial performance, warranting cautious investor analysis.
Earnings surprise occurs when a company's actual earnings differ from analysts' expectations. A positive earnings surprise typically reflects better-than-expected performance, potentially leading to stock appreciation. Conversely, a negative earnings surprise can result in stock depreciation. An earnings surprise of zero means the earnings met expectations, which typically has a neutral impact on stock price.
Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.
| 2023-12-31 | 2022-12-31 | Y/Y change % | |
|---|---|---|---|
| FY | |||
| calendar year | 2023 | 2022 | NaN |
| revenue per share | 23.74 | 23.63 | 0.48 |
| net income per share | -0.72 | 0.79 | -190.47 |
| operating cash flow per share | 1.63 | 2.0 | -18.28 |
| free cash flow per share | 1.24 | 1.64 | -24.72 |
| cash per share | 2.12 | 1.23 | 71.33 |
| book value per share | 10.11 | 10.68 | -5.40 |
| tangible book value per share | -6.62 | -11.52 | 42.51 |
| shareholders equity per share | 10.11 | 10.68 | -5.40 |
| interest debt per share | 8.85 | 9.5 | -6.86 |
| market cap | 781367613.9 | 1240319620 | -37.00 |
| enterprise value | 1409757613.9 | 1984063620 | -28.95 |
| pe ratio | -12.93 | 18.7 | -169.18 |
| price to sales ratio | 0.39 | 0.63 | -37.72 |
| pocfratio | 5.69 | 7.43 | -23.42 |
| pfcf ratio | 7.51 | 9.04 | -16.87 |
| pb ratio | 0.92 | 1.39 | -33.84 |
| ptb ratio | 0.92 | 1.39 | -33.84 |
| ev to sales | 0.71 | 1.01 | -29.75 |
| enterprise value over ebitda | 47.17 | 8.42 | 460.21 |
| ev to operating cash flow | 10.27 | 11.88 | -13.62 |
| ev to free cash flow | 13.56 | 14.46 | -6.24 |
| earnings yield | -0.08 | 0.05 | -244.55 |
| free cash flow yield | 0.13 | 0.11 | 20.29 |
| debt to equity | 0.83 | 0.85 | -2.22 |
| debt to assets | 0.32 | 0.32 | -1.52 |
| net debt to ebitda | 21.03 | 3.16 | 566.14 |
| current ratio | 1.24 | 0.89 | 38.96 |
| interest coverage | 0.17 | 4.35 | -96.00 |
| income quality | -2.27 | 2.67 | -185.20 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0.11 | 0.12 | -2.78 |
| research and ddevelopement to revenue | 0 | 0 | NaN |
| intangibles to total assets | 0.63 | 0.79 | -19.78 |
| capex to operating cash flow | 0.24 | 0.18 | 36.38 |
| capex to revenue | 0.02 | 0.02 | 10.91 |
| capex to depreciation | 0.92 | 0.83 | 10.53 |
| stock based compensation to revenue | 0.01 | 0.01 | -24.45 |
| graham number | 12.79 | 13.82 | -7.49 |
| roic | 0.0 | 0.07 | -92.50 |
| return on tangible assets | -0.07 | 0.13 | -155.34 |
| graham net net | -11.7 | -13.55 | 13.62 |
| working capital | 94508000 | -39475000 | 339.41 |
| tangible asset value | -556345000 | -961342000 | 42.13 |
| net current asset value | -887295000 | -1121505000 | 20.88 |
| invested capital | 1645847000 | 1880423000 | -12.47 |
| average receivables | 288332500 | 299281000 | -3.66 |
| average payables | 33222500 | 34251000 | -3.00 |
| average inventory | 0.5 | 1 | -50.00 |
| days sales outstanding | 51.21 | 54.93 | -6.77 |
| days payables outstanding | 8.03 | 7.73 | 3.87 |
| days of inventory on hand | 0 | 0.0 | -100.00 |
| receivables turnover | 7.13 | 6.64 | 7.26 |
| payables turnover | 45.48 | 47.24 | -3.73 |
| inventory turnover | 0 | 1504988000 | -100.00 |
| roe | -0.07 | 0.07 | -195.63 |
| capex per share | 0.4 | 0.36 | 11.45 |
ROE: Return on Equity (ROE) decreased to -0.07 on 2023-12-31 from 0.07 on 2022-12-31, representing a change of -195.63%. Suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -12.93 on 2023-12-31 from 18.70 on 2022-12-31, representing a change of -169.18%. Indicating a decrease in the relative valuation of the company's stock.
Current Ratio: Current Ratio increased to 1.24 on 2023-12-31 from 0.89 on 2022-12-31, representing a change of 38.96%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.
Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.83 on 2023-12-31 from 0.85 on 2022-12-31, representing a change of -2.22%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
| 2024-09-30 Q3 | 2024-06-30 Q2 | Q/Q change % | |
|---|---|---|---|
| MD | |||
| calendar year | 2024 | 2024 | NaN |
| revenue per share | 6.09 | 6.05 | 0.69 |
| net income per share | 0.23 | -1.84 | 112.62 |
| operating cash flow per share | 1.2 | 1.28 | -6.45 |
| free cash flow per share | 1.13 | 1.2 | -6.19 |
| cash per share | 2.63 | 1.6 | 64.41 |
| book value per share | 8.73 | 8.48 | 2.99 |
| tangible book value per share | -6.19 | -6.51 | 4.88 |
| shareholders equity per share | 8.73 | 8.48 | 2.99 |
| interest debt per share | 8.27 | 8.5 | -2.75 |
| market cap | 972296690 | 592490520 | 64.10 |
| enterprise value | 1552118690 | 1271398520 | 22.08 |
| pe ratio | 12.5 | -0.97 | 1391.70 |
| price to sales ratio | 1.9 | 1.17 | 61.90 |
| pocfratio | 9.65 | 5.54 | 74.26 |
| pfcf ratio | 10.3 | 5.93 | 73.76 |
| pb ratio | 1.33 | 0.84 | 58.27 |
| ptb ratio | 1.33 | 0.84 | 58.27 |
| ev to sales | 3.04 | 2.52 | 20.44 |
| enterprise value over ebitda | 37.3 | -8.55 | 536.01 |
| ev to operating cash flow | 15.41 | 11.89 | 29.63 |
| ev to free cash flow | 16.44 | 12.72 | 29.27 |
| earnings yield | 0.02 | -0.26 | 107.74 |
| free cash flow yield | 0.1 | 0.17 | -42.45 |
| debt to equity | 0.93 | 0.99 | -5.58 |
| debt to assets | 0.33 | 0.35 | -5.94 |
| net debt to ebitda | 13.93 | -4.57 | 405.03 |
| current ratio | 1.42 | 1.38 | 2.31 |
| interest coverage | 3.34 | 4.73 | -29.38 |
| income quality | 5.18 | -0.7 | 841.27 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0.11 | 0.11 | 1.37 |
| research and ddevelopement to revenue | 0 | 0 | NaN |
| intangibles to total assets | 0.6 | 0.63 | -3.70 |
| capex to operating cash flow | 0.06 | 0.07 | -4.06 |
| capex to revenue | 0.01 | 0.01 | -10.87 |
| capex to depreciation | 0.9 | 0.79 | 14.16 |
| stock based compensation to revenue | 0.01 | 0.0 | 107.73 |
| graham number | 6.75 | 18.72 | -63.95 |
| roic | 0.01 | 0.03 | -41.98 |
| return on tangible assets | 0.02 | -0.21 | 111.49 |
| graham net net | -10.82 | -11.4 | 5.08 |
| working capital | 155135000 | 119056000 | 30.30 |
| tangible asset value | -519698000 | -542739000 | 4.25 |
| net current asset value | -816166000 | -859678000 | 5.06 |
| invested capital | 1505813000 | 1481541000 | 1.64 |
| average receivables | 281129500 | 278956500 | 0.78 |
| average payables | 39683500 | 31818000 | 24.72 |
| average inventory | 0 | 0.5 | -100.00 |
| days sales outstanding | 50.73 | 48.93 | 3.67 |
| days payables outstanding | 10.81 | 7.22 | 49.76 |
| days of inventory on hand | 0 | 0 | NaN |
| receivables turnover | 1.77 | 1.84 | -3.54 |
| payables turnover | 8.33 | 12.47 | -33.23 |
| inventory turnover | 0 | 0 | NaN |
| roe | 0.03 | -0.22 | 112.25 |
| capex per share | 0.07 | 0.08 | -10.25 |
ROE: Return on Equity (ROE) increased to 0.03 on 2024-09-30 Q3 from -0.22 on 2024-06-30 Q2, representing a change of 112.25%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio increased to 12.50 on 2024-09-30 Q3 from -0.97 on 2024-06-30 Q2, representing a change of 1391.70%. Indicating an increase in the relative valuation of the company's stock.
Current Ratio: Current Ratio increased to 1.42 on 2024-09-30 Q3 from 1.38 on 2024-06-30 Q2, representing a change of 2.31%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.
Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.93 on 2024-09-30 Q3 from 0.99 on 2024-06-30 Q2, representing a change of -5.58%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
Negative Sentiment: Discounted Cash Flow value is 9.8 which is lower than current price 13.84, indicates the company may be overvalued.
| Market Capitalization | Enterprise Value | |
|---|---|---|
| Definition | The total market value of a company's outstanding shares | The total market value of a company, including its debt and other liabilities |
| Calculation | Current share price * Total number of outstanding shares | Market capitalization + Total debt - Cash and cash equivalents |
| Focus | Equity component of a company's value | Total economic value of a company |
| Usefulness | Assesses a company's size and growth potential based on investor sentiment | Provides a more comprehensive valuation that considers both equity and debt |
Analyzing dividends is a crucial aspect of investment evaluation, offering valuable insights into a company's financial health and its commitment to shareholder returns. Dividends represent a portion of a company's profits distributed to its shareholders, providing a steady income stream. We help you analyze dividends based on the indicators mentioned below:
• Investors often assess the average dividend amount, observing trends over time to gauge the company's stability and growth potential. A positive trend in average dividends indicates a consistent and potentially lucrative investment. Additionally, evaluating the trend of dividend increases provides insight into the company's financial strength and management's confidence in future earnings.
• Consistency in paying dividends is a reassuring sign, reflecting a company's reliability and commitment to shareholder value. For investors, dividends not only offer income but also contribute to the overall total return on investment.
• Companies with a history of regular and increasing dividends can attract income-focused investors seeking stable returns, making dividends a critical factor in building a well-rounded investment portfolio.
Interested in the overall sentiment for a particular period? Check out our news sentiment analysis tool.
Sentiment: Positive
Publish Date: 2025-01-13 12:41:13
Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). But which of these two stocks is more attractive to value investors?
Sentiment: Positive
Publish Date: 2025-01-13 06:00:00
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Announces Strategic Initiatives For Enhanced Shareholder Value Creation.
Sentiment: Positive
Publish Date: 2025-01-01 10:51:42
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Sentiment: Positive
Publish Date: 2024-12-27 12:40:22
Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). But which of these two companies is the best option for those looking for undervalued stocks?
Sentiment: Positive
Publish Date: 2024-12-27 11:11:48
Stable same-facility patient volume growth, inorganic initiatives and transition to an RCM structure should aid MD's future growth.
Sentiment: Neutral
Publish Date: 2024-12-19 13:57:29
The Healthcare sector sees volume growth and improved occupancy while battling rising medical costs and regulatory uncertainty.
Sentiment: Positive
Publish Date: 2024-12-16 10:41:04
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Sentiment: Positive
Publish Date: 2024-12-11 12:40:23
Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). But which of these two companies is the best option for those looking for undervalued stocks?
Sentiment: Positive
Publish Date: 2024-11-26 09:50:27
Pediatrix Medical Group (MD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Sentiment: Positive
Publish Date: 2024-11-25 12:46:26
Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). But which of these two stocks offers value investors a better bang for their buck right now?
Sentiment: Positive
Publish Date: 2024-11-08 09:51:14
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Pediatrix Medical Group (MD) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Sentiment: Neutral
Publish Date: 2024-11-07 12:56:13
MD expects transformational and restructuring-related expenses to be $48 million in 2024.
Sentiment: Positive
Publish Date: 2024-11-07 12:40:47
Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or Avantor, Inc. (AVTR). But which of these two companies is the best option for those looking for undervalued stocks?
Sentiment: Positive
Publish Date: 2024-11-01 11:52:06
Pediatrix Medical Group, Inc. (NYSE:MD ) Q3 2024 Earnings Conference Call November 1, 2024 9:00 AM ET Company Participants Charles Lynch - Senior Vice President, Finance and Strategy James Swift - Chief Executive Officer Kasandra Rossi - Executive Vice President, Chief Financial Officer and Treasure Conference Call Participants Jack Senft - William Blair Jack Slevin - Jefferies A.J. Rice - UBS Operator Ladies and gentlemen, thank you for standing by and welcome to the 2024 Third Quarter's Earnings Conference.
Sentiment: Positive
Publish Date: 2024-11-01 08:11:16
Pediatrix Medical Group (MD) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.32 per share a year ago.
Sentiment: Neutral
Publish Date: 2024-11-01 06:00:00
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports Third Quarter Results.
Sentiment: Positive
Publish Date: 2024-10-25 11:06:34
Pediatrix Medical Group (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
* The sentiment analysis presented is generated through an algorithm and may be subject to inaccuracies. Users are advised to corroborate key information and employ further analytical methods prior to making critical decisions.
Get instant AI-powered professional insights:
💡Generate AI Technical Analysis ReportUnderstand the chart below:
Interpret Technical Indicators
| Indicator | Bullish | Bearish |
|---|---|---|
| Price and EMA ⓘ | Price crosses above EMA | Price crosses below EMA |
| Short-Term vs Long-Term EMA ⓘ | Short EMA crosses above Long EMA | Short EMA crosses below Long EMA |
| Volume ⓘ | Increasing volume during price uptrend | Increasing volume during price downtrend |
| MACD ⓘ | MACD crosses above Signal Line | MACD crosses below Signal Line |
| RSI ⓘ | RSI is below 30 (oversold) and starts to rise above 30 | RSI is above 70 (overbought) and starts to decline below 70 |
| Candlestick Patterns ⓘ | Bullish candlestick patterns | Bearish candlestick patterns |
Copyright © 2024 Sirius Investors
All rights reserved
